Am j clin oncol
[DOC File]ADAM CIEN
https://info.5y1.org/am-j-clin-oncol_1_79556f.html
J Clin Oncol 2008;26:729-735. 12. Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 2008;26:721-728. 13. Zhu CQ, Ding K, Strumpf D, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol 2010;28 ...
[DOC File]Carcinoma of the Skin - College of American Pathologists
https://info.5y1.org/am-j-clin-oncol_1_856a46.html
J Clin Oncol . 2020, 38 (suppl; abstr 534). Accepted for poster presentation at the 2020 ASCO Annual Meeting (online meeting due to COVID-19), Chicago, IL, May 29-June 2, 2020.
American Journal of Clinical Oncology - Wikipedia
Am J Clin Oncol. 2014 Jan 7. [Epub ahead of print] 81.Dikken JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde CJ, Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy.
[DOC File]Supplementary Methods, Figures and Tables
https://info.5y1.org/am-j-clin-oncol_1_0ceb61.html
Am J Hum Genet. 2003;72:1117-1130. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329-1333. Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005;104:2807-2816. National Comprehensive Cancer Network.
[DOCX File]cp-skin-melanoma-excision-20-4200
https://info.5y1.org/am-j-clin-oncol_1_8b2381.html
J Clin Oncol. 2011 Jun 10;29(17):2378-85. Epub 2011 May 2. PubMed PMID: 21537045; PubMed Central PMCID: PMC3107752. 54. Flavin RJ, Cook J, Fiorentino M, Bailey D, Brown M, Loda MF. ?-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis. Am J Clin Pathol. 2011 May;135(5):776-82.
[DOCX File]School of Medicine | University of Colorado
https://info.5y1.org/am-j-clin-oncol_1_638d3c.html
Am J Clin Oncol. 1991;14(1):38-44. 33.O'Brien ME, Wigler N, Inbar M, et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.
[DOC File]SAMPLE CURRICULUM VITAE .edu
https://info.5y1.org/am-j-clin-oncol_1_83edd1.html
Smith DE, Bielamowicz S, Kagan AR, Anderson PJ, Peddada AV. Cutaneous neuroendocrine (Merkel cell) carcinoma: a report of 35 cases. Am J Clin Oncol. 1995;18:199-203. Smith KJ, Skelton HG, Holland TT. Recent advances and controversies concerning adnexal neoplasms. Dermatol Clin. 1992;10:117-160.
[DOC File]BRCAdvantage Letter of Medical Necessity
https://info.5y1.org/am-j-clin-oncol_1_aeecf4.html
J Clin Oncol. 2002; 20: 1105-14. 10. Daher T, Tur MK, Brobeil A, Etschmann B, Witte B, Engenhart-Cabillic R, et al. Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
[DOCX File]Dove Medical Press
https://info.5y1.org/am-j-clin-oncol_1_c32505.html
J Clin Oncol. 2008;26(26):4296-4303. 4.van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
[DOCX File]VCLIC News and Happenings, Volume 3
https://info.5y1.org/am-j-clin-oncol_1_48137b.html
Am J Clin Oncol. 2015; 38(4): 401-404. Vargo JA, Heron DE, Ferris Rl, Rwigema JC, Kalash R, Wegner RE, Ohr J, Burton S. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of …
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.